David Tobias - Cannabis Sativa Interim CEO and Director

All Insiders . USA . 
Stock . Cannabis Sativa . Stakeholders . Insider . David Tobias
CBDS Stock  USD 0.06  0.01  28.89%   

CEO

Mr. David Tobias is President, Director of the Company. He served as President of Wild Earth Naturals since May, 2013. He also served as the President of Hemp, Inc. from August 2011 to January 9, 2014. Prior to that, from October 2009 until May 2011, Mr. Tobias held the position of Vice President at Medical Marijuana Inc. where he was instrumental in bringing forward and culminating the merger between CannaBank and Medical Marijuana, Inc. He was earlier Sales Manager for Tulsa custom builder Xcite Homes, from October 2008 to August 2009. Among other qualifications, Mr. Tobias brings to the Board executive leader ship experience, including his service as a president of a public company, along with extensive entrepreneurial experience. Mr. Tobias also has a keen sense of the social, political, and economic environment in which the company operates. since 2016.
Age 72
Tenure 8 years
Phone702 763 3123
Webhttps://cannabissativainc.com
Tobias has served as President of Wild Earth Naturals, a wholly owned subsidiary of the Company, since May, 2013. He also served as the President of Hemp, Inc. from August 2011 to January 9, 2014. Prior to that, from October 2009 until May 2011, Mr. Tobias held the position of Vice President at Medical Marijuana Inc. where he was instrumental in bringing forward and culminating the merger between CannaBank and Medical Marijuana, Inc. He was earlier Sales Manager for Tulsa custom builder Xcite Homes, from October 2008 to August 2009. Among other qualifications, Mr. Tobias has executive leader ship experience, including his service as a president of a public company, along with extensive entrepreneurial experience.

Cannabis Sativa Management Efficiency

The company has return on total asset (ROA) of (0.2894) % which means that it has lost $0.2894 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5405) %, meaning that it created substantial loss on money invested by shareholders. Cannabis Sativa's management efficiency ratios could be used to measure how well Cannabis Sativa manages its routine affairs as well as how well it operates its assets and liabilities.
Cannabis Sativa currently holds 125.46 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Cannabis Sativa has a current ratio of 2.31, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cannabis Sativa until it has trouble settling it off, either with new capital or with free cash flow. So, Cannabis Sativa's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cannabis Sativa sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cannabis to invest in growth at high rates of return. When we think about Cannabis Sativa's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CEO Age

Scott BoruffHealthcare Integrated Technolog
60
Robert McDermottiCoreConnect Common stock
57
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. Cannabis Sativa operates under Health Information Services classification in the United States and is traded on OTC Exchange. Cannabis Sativa [CBDS] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Equity-0.54
Return On Asset-0.29

Cannabis Sativa Leadership Team

Elected by the shareholders, the Cannabis Sativa's board of directors comprises two types of representatives: Cannabis Sativa inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cannabis. The board's role is to monitor Cannabis Sativa's management team and ensure that shareholders' interests are well served. Cannabis Sativa's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cannabis Sativa's outside directors are responsible for providing unbiased perspectives on the board's policies.
Catherine Carroll, CFO, Treasurer and Director
David Tobias, Interim CEO and Director
Brad Herr, CFO Director
Carolyn Merrill, Controller

Cannabis Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Cannabis Sativa a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.54
Return On Asset-0.29
Profit Margin(0.56) %
Operating Margin(0.79) %
Current Valuation1.2 M
Shares Outstanding44.87 M
Shares Owned By Insiders39.10 %
Price To Earning(7.53) X
Price To Book1.86 X
Price To Sales1.15 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cannabis OTC Stock Analysis

When running Cannabis Sativa's price analysis, check to measure Cannabis Sativa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Sativa is operating at the current time. Most of Cannabis Sativa's value examination focuses on studying past and present price action to predict the probability of Cannabis Sativa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Sativa's price. Additionally, you may evaluate how the addition of Cannabis Sativa to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY